Home › NDC Lookup › RxCUI directory › RxCUI 1099446

Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet — RxCUI 1099446

RxNorm drug concept · Semantic clinical drug
RxCUI 1099446 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1099446
Official namePseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspseudoephedrine HCl 60 MG / triprolidine HCl 2.5 MG Oral Tablet
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)16,628 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pseudoephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Many products also relieve sinus congestion and pressure.
  • It depends on the product. Regular tablets and softgels are usually taken every 4 to 6 hours, while 12-hour extended-release tablets are taken every 12 hours. Check your box for th...
  • No. Swallow them whole. Don't divide, crush, chew or dissolve them. Seeing part of the tablet in your stool can happen and is normal.
  • Can I crush or chew the extended-release tablets?
📖 Read our full Pseudoephedrine guide →

🕸️ Concept Web — How Pseudoephedrine hydrochloride 60 MG / triprolidi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet RxCUI 1099446

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Pseudoephedrine 8896
    • Triprolidine 10849
    • Pseudoephedrine / triprolidine 214807
    • Pseudoephedrine hydrochloride 91168
    • Triprolidine hydrochloride 71534
  2. Brand names 4

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aphedrid 215364
    • Genac brand of pseudoephedrine/triprolidine 217282
    • Vi-Sudo 220801
    • Wal-Act 1014651
  3. Dose forms 25

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pseudoephedrine / triprolidine Oral Tablet 374247
    • Pseudoephedrine hydrochloride / triprolidine hydrochloride Oral Tablet 2647119
    • Pseudoephedrine / triprolidine Oral Product 1163564
    • Pseudoephedrine / triprolidine Pill 1163565
    • Pseudoephedrine hydrochloride / triprolidine hydrochloride Oral Product 2659735
    • Pseudoephedrine hydrochloride / triprolidine hydrochloride Pill 2662249
    • Pseudoephedrine / triprolidine Oral Tablet [Aphedrid] 369046
    • Pseudoephedrine / triprolidine Oral Tablet [Genac brand of pseudoephedrine/triprolidine] 1099592
    • +17 more in this family
  4. Clinical & branded drugs 10

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pseudoephedrine hydrochloride 60 MG 996721
    • Triprolidine hydrochloride 2.5 MG 1099445
    • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Aphedrid] 1099583
    • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Genac brand of pseudoephedrine/triprolidine] 1099593
    • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Vi-Sudo] 1099770
    • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Wal-Act] 1099774
    • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG [Aphedrid] 1099582
    • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG [Genac brand of pseudoephedrine/triprolidine] 1099591
    • +2 more in this family

Showing up to 8 concepts per family — 25 of 44 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pseudoephedrine hydrochloride 60 MG SCDC · 996721
  • Triprolidine hydrochloride 2.5 MG SCDC · 1099445
  • Pseudoephedrine / triprolidine Oral Tablet SCDF · 374247
  • Pseudoephedrine hydrochloride / triprolidine hydrochloride Oral Tablet SCDFP · 2647119
  • Pseudoephedrine / triprolidine Oral Product SCDG · 1163564
  • Pseudoephedrine / triprolidine Pill SCDG · 1163565
  • Pseudoephedrine hydrochloride / triprolidine hydrochloride Oral Product SCDGP · 2659735
  • Pseudoephedrine hydrochloride / triprolidine hydrochloride Pill SCDGP · 2662249

Brand-Name Concepts

  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Aphedrid] SBD · 1099583
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Genac brand of pseudoephedrine/triprolidine] SBD · 1099593
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Vi-Sudo] SBD · 1099770
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG Oral Tablet [Wal-Act] SBD · 1099774
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG [Aphedrid] SBDC · 1099582
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG [Genac brand of pseudoephedrine/triprolidine] SBDC · 1099591
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG [Vi-Sudo] SBDC · 1099769
  • Pseudoephedrine hydrochloride 60 MG / triprolidine hydrochloride 2.5 MG [Wal-Act] SBDC · 1099773
  • Pseudoephedrine / triprolidine Oral Tablet [Aphedrid] SBDF · 369046
  • Pseudoephedrine / triprolidine Oral Tablet [Genac brand of pseudoephedrine/triprolidine] SBDF · 1099592

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 1099446 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0287-22 2 BLISTER PACK in 1 CARTON (0363-0287-22) / 24 TABLET, FILM... Cold and Allergy D Walgreen Company 2022-11-29
00904-7302-24 1 BLISTER PACK in 1 CARTON (0904-7302-24) / 24 TABLET, FILM... Aprodine Major Pharmaceuticals 2022-11-11
00904-7302-60 1 BOTTLE, PLASTIC in 1 CARTON (0904-7302-60) / 100 TABLET,... Aprodine Major Pharmaceuticals 2022-11-11
50090-7085-02 1 BLISTER PACK in 1 CARTON (50090-7085-2) / 24 TABLET, FILM... APRODINE A-S Medication Solutions 2024-02-05
Observed labelers: Major Pharmaceuticals (2) · A-S Medication Solutions (1) · Walgreen Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.0720
Range $0.0720–$0.0720 · middle 50% $0.0720–$0.0720 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.